Skip to main content

Want a detailed portfolio tracker?

Channel Therapeutics (PTHS) P/E (2024 - 2026)

Channel Therapeutics (PTHS) P/E from Feb 16, 2024 to Jun 3, 2026. The TTM Channel Therapeutics (PTHS) P/E is -0.66. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Channel Therapeutics (PTHS)

YearP/EChange
2026-0.66-16.20%
2025-0.79+67.43%
2024-0.47N/A

Comparison Channel Therapeutics (PTHS) P/E with competitors

Channel Therapeutics (PTHS) P/E is -0.66.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.26%
NBYStablecoin Development Corp0.10-115.40%
ENLVEnlivex Therapeutics Ltd0.15-122.62%
FGENFibroGen Inc0.24-136.15%
TRAWTraws Pharma Inc0.47-171.21%
FBIOFortress Biotech Inc0.71-206.33%
CHRSCoherus Biosciences Inc0.98-247.31%
ORMPOramed Pharmaceuticals Inc1.47-321.91%
AGENAgenus Inc2.05-408.51%
VIVSVivoSim Labs Inc2.54-481.91%
INVAInnoviva Inc3.19-580.21%
CRMDCorMedix Inc3.65-649.07%
ABEOAbeona Therapeutics Inc4.20-733.31%
VXRTVaxart Inc4.26-741.84%
CVACCureVac N.V.4.45-769.55%
SRPTSarepta Therapeutics Inc4.62-796.45%
GLPGGalapagos NV4.86-831.78%
RIGLRigel Pharmaceuticals4.92-840.92%
ZVRAZevra Therapeutics Inc4.97-849.13%
ABUSArbutus Biopharma Corp5.69-957.53%
CGENCompugen Ltd7.38-1212.09%
AUPHAurinia Pharmaceuticals Inc9.25-1493.36%
ACADAcadia Pharmaceuticals Inc9.59-1544.06%
OMEROmeros Corporation9.88-1588.55%
PLXProtalix BioTherapeutics Inc9.91-1592.42%
SPROSpero Therapeutics Inc10.73-1716.77%
ADMAAdma Biologics Inc11.33-1806.52%
SVASinovac Biotech Ltd11.44-1822.39%
TBPHTheravance Biopharma Inc11.78-1873.69%
HRMYHarmony Biosciences Holdings Inc12.18-1934.51%
TGTXTG Therapeutics Inc13.18-2084.97%
INCYIncyte Corp13.38-2115.48%
SABSSAB Biotherapeutics Inc14.06-2217.25%
XOMAXOMA Corp14.95-2350.92%
REGNRegeneron Pharmaceuticals Inc14.98-2356.19%
PBYIPuma Biotechnology Inc15.05-2366.76%
EXELExelixis Inc15.79-2478.88%
NAGENiagen Bioscience Inc16.35-2563.24%
CPRXCatalyst Pharmaceuticals Inc17.34-2712.31%
MDXGMimedx Group Inc17.38-2716.92%
ARGXArgen X SE23.07-3574.84%
HALOHalozyme Therapeutics Inc23.20-3594.27%
XOMAOXOMA Corp25.34-3917.21%
VRTXVertex Pharmaceuticals Inc25.66-3964.05%
XOMAPXOMA Corp25.67-3966.21%
CTMXCytomX Therapeutics Inc25.70-3970.40%
ASNDAscendis Pharma A/S26.35-4069.23%
RPRXRoyalty Pharma plc - Class A27.50-4241.12%
SLNOSoleno Therapeutics Inc29.02-4470.04%
LGNDLigand Pharmaceuticals Inc - Class B30.19-4646.43%
BMRNBiomarin Pharmaceutical Inc37.51-5749.02%
APLSApellis Pharmaceuticals Inc39.02-5977.04%
KRYSKrystal Biotech Inc39.70-6078.91%
GMABGenmab40.20-6155.12%
ONCBeiGene Ltd67.03-10195.03%
TECHBio-Techne Corp68.59-10431.21%
VCELVericel Corp80.63-12243.69%
PHARPharming Group N.V.87.74-13314.68%
ALNYAlnylam Pharmaceuticals Inc124.93-18916.46%
TLXTelix Pharmaceuticals Ltd139.89-21169.16%
CORTCorcept Therapeutics Inc158.39-23955.26%